image_pdfimage_print
25 02, 2022

HB 4348

AN ACT to license and regulate pharmacy benefit managers; to require reporting of certain data; to provide for the powers and duties of certain state governmental officers and entities; to provide remedies; to require the promulgation of rules; and to require and to provide sanctions for violation of this act.

HB 4348
19 01, 2022

HB 4346

House Bill 4346 would amend the Insurance Code to require an insurer that delivers, issues for delivery, or renews a health insurance policy that provides coverage for prescription insulin to cap the total amount the insured person is required to pay for the prescription at $50 per 30-day supply of insulin, regardless of the amount or type of insulin needed.

HB 4346
19 01, 2022

HB 4347

House Bill 4347 would create a new act, the Drug Manufacturer Data Reporting Act, which would require drug manufacturers to disclose certain information on costs and pricing to the Department of Insurance and Financial Services (DIFS) on an annual basis. A drug manufacturer would have to submit a report to the DIFS director within 30 days after increasing the wholesale acquisition cost of a qualified prescription drug by 15% or more in a given year or by 40% or more over a three-year period. A drug manufacturer would have to notify the DIFS director [...]

HB 4347
19 01, 2022

HB 4351

House Bill 4351 would amend the Third Party Administrator Act. The bill would require that a contract between a carrier or pharmacy benefit manager and a pharmacy not prohibit the pharmacy from disclosing the current selling price of a drug in accordance with section 17757 of the Public Health Code, as it would be amended by HB 4352. Additionally, the bill would prohibit a carrier or pharmacy benefit manager that reimburses a 340B entity for drugs under federal law from reimbursing the 340B entity for pharmacy dispensed drugs or provider-administered drugs at a rate [...]

HB 4351
19 01, 2022

HB 4352

House Bill 4352 would amend the Public Health Code. Currently under the code, if a pharmacist who sells drugs at retail is asked, he or she must provide the current selling price of a drug the pharmacy dispenses or comparative current selling prices of generic and brand name drugs it dispenses. This information must be given before a drug is dispensed. Asking for this information does not oblige a person to buy a drug asked about. The bill would retain these provisions, but would amend them to allow a pharmacist to provide this information [...]

HB 4352